You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-ATR antibody - ChIP Grade (ab2905)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab2905? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab2905 has been referenced in 7 publications.

  1. Vadnais C et al. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage. Nucleic Acids Res : (2012). WB; Human, Mouse. PubMed: 22319212
  2. Lin Y et al. Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis. Mol Cell Biol 30:4435-51 (2010). ChIP; Human. PubMed: 20647539
  3. Siehler SY et al. Human MutL-complexes monitor homologous recombination independently of mismatch repair. DNA Repair (Amst) 8:242-52 (2009). PubMed: 19022408
  4. Nakayama Y et al. Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway. Exp Cell Res 315:2515-28 (2009). WB. PubMed: 19527713
  5. Yoshioka K et al. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol Cell 22:501-10 (2006). PubMed: 16713580
  6. Kedde M et al. Telomerase-independent regulation of ATR by human telomerase RNA. J Biol Chem 281:40503-14 (2006). PubMed: 17098743
  7. Hovest MG et al. Senescence of human fibroblasts after psoralen photoactivation is mediated by ATR kinase and persistent DNA damage foci at telomeres. Mol Biol Cell 17:1758-67 (2006). WB. PubMed: 16436511

Publishing research using ab2905? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"